Up 58% YTD, is Eli Lilly Stock Still a Buy? - The Globe and Mail

Aug 19, 2024 · The Street-high price target of $1,117 suggests that Eli Lilly stock could rise as much as 21.4% from here. At nearly 58x forward adjusted earnings, LLY stock is definitely …

CouponFollow Extension

58%
OFF

Up 58% YTD, Is Eli Lilly Stock Still A Buy? - The Globe And Mail

3 weeks from now

Aug 19, 2024 · The Street-high price target of $1,117 suggests that Eli Lilly stock could rise as much as 21.4% from here. At nearly 58x forward adjusted earnings, LLY stock is definitely …

theglobeandmail.com

58%
OFF

Up 58% YTD, Is Eli Lilly Stock Still A Buy? - Nasdaq

3 weeks from now

Aug 19, 2024 · The Street-high price target of $1,117 suggests that Eli Lilly stock could rise as much as 21.4% from here. At nearly 58x forward adjusted earnings, LLY stock is definitely …

nasdaq.com

5%
OFF

Is Eli Lilly Stock Still A Buy Near All-Time Highs ... - The Globe And …

3 weeks from now

Sep 25, 2024 · Eli Lilly (LLY) stock is trading near its all-time highs, with the shares only about 5% away from the record levels set in August. With the shares up nearly 68% in the past 52 weeks …

theglobeandmail.com

58%
OFF

Up 58% YTD, Is Eli Lilly Stock Still A Buy? - Barchart.com

3 weeks from now

The pharmaceutical giant has already delivered massive gains this year, but Wall Street analysts have only gotten more bullish on the maker of Mounjaro and Zepbound.

barchart.com

58%
OFF

Up 58% YTD, Is Eli Lilly Stock Still A Buy? - TradingView

3 weeks from now

Aug 19, 2024 · With operations across the globe, LLY is headquartered out of Indianapolis. LLY stock has been on a tear over the past year, driven by the blockbuster success of its Type II …

tradingview.com

25%
OFF

Eli Lilly: Recent Pullback Opens Buy Window As Stock Prepares For …

3 weeks from now

Nov 6, 2024 · Eli Lilly's price pullback presents investors with an opportunity. The stock has a healthy 25% upside from critical support targets.

investing.com

60%
OFF

Should You Buy Eli Lilly Stock Now Or Wait For A Dip?

3 weeks from now

Dec 7, 2023 · Up 60% this year, Eli Lilly has hit new all-time highs amid the excitement around Zepbound. Should investors still buy the stock at its lofty valuation, or are you better off waiting …

theglobeandmail.com

58%
OFF

Eli Lilly Stock Analysis: Still A Buy After 58% YTD Gain? - Upalpha.com

3 weeks from now

Aug 19, 2024 · Explore whether Eli Lilly (LLY) stock is still a buy after its 58% YTD surge. Analyze key factors driving growth and what analysts are forecasting.

upalpha.com

$45
OFF

Eli Lilly Stock Update: What Investors Should Watch In 2025

3 weeks from now

6 days ago · Investors might keep in mind that Eli Lilly still projects substantial top-line growth for 2024 and especially for 2025. The company expects $45 billion in revenue for 2024 and …

marketbeat.com

FAQs about Up 58% YTD, is Eli Lilly Stock Still a Buy? - The Globe and Mail Coupon?

Is Eli Lilly (LLY) stock trading near its all-time highs?

Eli Lilly (LLY) stock is trading near its all-time highs, with the shares only about 5% away from the record levels set in August. ...

Is Eli Lilly a good stock to buy?

Eli Lilly has seen explosive share price growth over the past year. Its weight loss and diabetes treatments are growing sales rapidly, but it's not resting on its laurels. Lilly's ability to stay ahead of the game can allow it to keep winning going forward. In a year and a half, Eli Lilly (NYSE: LLY) has roughly doubled in value. ...

What happened to Eli Lilly shares in 2024?

2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (LLY 1.57%). At one point, share prices had gained as much as 65% on the year. However, after a less-than-spectacular earnings report published in late October, shares of Lilly started to slide considerably. ...

Is Eli Lilly stock cratering?

While this could suggest the company is experiencing sluggish or plateauing growth in its major businesses, the finer details suggest otherwise. Shares of pharmaceutical stock Eli Lilly are cratering after the company lowered its sales guidance for Q4. 2024 was an interesting year for pharmaceutical powerhouse Eli Lilly (LLY 1.57%). ...

Is Eli Lilly stock a top performer?

Eli Lilly (NYSE: LLY) stock has been a top performer thanks to runaway sales of its diabetes-turned-weight-management treatment. Despite nearly doubling over the past 12 months, Eli Lilly stock still has heaps of upside according to investment bank analysts who follow the century-old pharmaceutical giant. ...

Why did Eli Lilly stock fall 14% over the past 3 months?

But over the past three months, the stock has fallen by 14% as the recent election results don't appear to be inspiring much enthusiasm around the business. Fears of heightened oversight in the industry could weigh on not just Eli Lilly, but healthcare stocks as a whole. ...